🔎 Trials Near Me

መነሻ › የእንቁላል ካንሰር › Wisconsin › Madison

በMadison፣ WI ለየእንቁላል ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየእንቁላል ካንሰር የሚደረጉ 13 ጥናቶች በMadison እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT07001748

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Wisconsin Carbone Cancer Center, Madison
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT04585750

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • UW Health Carbone Cancer Center, Madison
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06760819

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Research Site, Madison
እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT05489211

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07213804

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Wisconsin - Carbone Cancer Center, Madison
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07213791

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Wisconsin, Madison
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT06787612

Cognitive Impact of Neoadjuvant Chemotherapy for Gynecologic Cancers

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • UW Carbone Cancer Center, Madison
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ27 ኦገስ 2026 · NCT07125209

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

ተሳታዮችን በመፈለግ ላይ
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
እድሜ ከ35 እስከ 50 · ሴቶች · የተሻሻለው በ7 ኦገስ 2026 · NCT04251052

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Wisconsin - Carbone Cancer Center - University Hospital, Madison
እድሜ ከ18 እስከ 100 · ሴቶች · የተሻሻለው በ13 ጁላይ 2026 · NCT05887609

Lead-212 PSV359 Therapy for Patients With Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Wisconsin, Madison
እድሜ ከ18 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT06710756

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Wisconsin Carbone Cancer Center, Madison
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ጁን 2026 · NCT05568680

በሌሎች ከተሞች ለየእንቁላል ካንሰር የሚደረጉ ጥናቶች

በMadison ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።